Home
AKRO
AKRO News

Latest Akero Therapeutics Inc. (AKRO) News on July 27, 2024

MT Newswires

13 hours ago

Akero Therapeutics Insider Sold Shares Worth $4,381,867, According to a Recent SEC Filing

Akero Therapeutics (AKRO) Moves to Buy: Rationale Behind the Upgrade

Zacks

10 days ago

Akero Therapeutics (AKRO) Moves to Buy: Rationale Behind the Upgrade

MT Newswires

2 months ago

Wolfe Research Initiates Coverage on Akero Therapeutics With Outperform Rating, $40 Price Target

Akero Therapeutics Announces Initiation of Phase 3 SYNCHRONY Outcomes Trial of Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

GlobeNewswire

2 months ago

Akero Therapeutics Announces Initiation of Phase 3 SYNCHRONY Outcomes Trial of Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024

GlobeNewswire

2 months ago

Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024

Viking (VKTX) Falls 10% Despite Upbeat NASH Study Results

Zacks

2 months ago

Viking (VKTX) Falls 10% Despite Upbeat NASH Study Results

Akero Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

Akero Therapeutics to Present at the Jefferies Global Healthcare Conference

MT Newswires

2 months ago

Evercore ISI Adjusts Price Target on Akero Therapeutics to $38 From $50, Maintains Outperform Rating

Akero Therapeutics Inc (AKRO) Q1 2024 Earnings: Misses Analyst Forecast Amid Continued ...

GuruFocus.com

2 months ago

Akero Therapeutics Inc (AKRO) Q1 2024 Earnings: Misses Analyst Forecast Amid Continued ...

MT Newswires

3 months ago

Akero Therapeutics' Q1 Net Loss Widens; Cash Expected to Fund Operations Into H2 2027

Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

3 months ago

Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference

GlobeNewswire

3 months ago

Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference

Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

GlobeNewswire

3 months ago

Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

Billionaire Steve Cohen and Insiders Are Buying These 10 Stocks

Insider Monkey

4 months ago

Billionaire Steve Cohen and Insiders Are Buying These 10 Stocks

Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That

The Wall Street Journal

4 months ago

Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That

Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH

Zacks

4 months ago

Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH

Ionis (IONS) Drug Meets Mid-Stage MASH Study Goals

Zacks

4 months ago

Ionis (IONS) Drug Meets Mid-Stage MASH Study Goals

Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewswire

5 months ago

Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology

GlobeNewswire

5 months ago

Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology

President and CEO Andrew Cheng Sells 75,000 Shares of Akero Therapeutics Inc (AKRO)

GuruFocus.com

5 months ago

President and CEO Andrew Cheng Sells 75,000 Shares of Akero Therapeutics Inc (AKRO)

Akero Therapeutics Announces Pricing of Public Offering of Common Stock

GlobeNewswire

5 months ago

Akero Therapeutics Announces Pricing of Public Offering of Common Stock

Akero (AKRO) Up on Upbeat Week 96 Data From Liver Disease Study

Zacks

5 months ago

Akero (AKRO) Up on Upbeat Week 96 Data From Liver Disease Study

Akero Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire

5 months ago

Akero Therapeutics Announces Proposed Public Offering of Common Stock

Why Akero Rocketed — And Pulled Rival 89bio Higher — On Results In Liver Disease Treatment

Investor's Business Daily

5 months ago

Why Akero Rocketed — And Pulled Rival 89bio Higher — On Results In Liver Disease Treatment

Data Suggests Makers of Fatty Liver Treatments Won’t Be Displaced by Obesity Drugs

The Wall Street Journal

5 months ago

Data Suggests Makers of Fatty Liver Treatments Won’t Be Displaced by Obesity Drugs

Akero Therapeutics Bats Back Challenge From Lilly in Emerging Liver-Drug Market

Barrons.com

5 months ago

Akero Therapeutics Bats Back Challenge From Lilly in Emerging Liver-Drug Market

Akero Rockets 27%, Prodding Rival 89bio Higher, On Promising Liver Disease Treatment

Investor's Business Daily

5 months ago

Akero Rockets 27%, Prodding Rival 89bio Higher, On Promising Liver Disease Treatment

Reuters

5 months ago

UPDATE 1-Akero's lead drug helps reduce scarring in fatty liver disease patients

Reuters

5 months ago

Akero's lead drug helps improve scarring in fatty liver disease patients

Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study

GlobeNewswire

5 months ago

Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study

Akero strengthens MASH drug’s case with new study data

BioPharma Dive

5 months ago

Akero strengthens MASH drug’s case with new study data

Wall Street Analysts Predict a 58.87% Upside in Akero Therapeutics, Inc. (AKRO): Here's What You Should Know

Zacks

5 months ago

Wall Street Analysts Predict a 58.87% Upside in Akero Therapeutics, Inc. (AKRO): Here's What You Should Know

Akero Therapeutics to Present Topline Week 96 Results from Phase 2b HARMONY Study Investigating Efruxifermin in Patients with Pre-Cirrhotic MASH

GlobeNewswire

5 months ago

Akero Therapeutics to Present Topline Week 96 Results from Phase 2b HARMONY Study Investigating Efruxifermin in Patients with Pre-Cirrhotic MASH

Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

5 months ago

Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Are Medical Stocks Lagging GSK PLC Sponsored ADR (GSK) This Year?

Zacks

5 months ago

Are Medical Stocks Lagging GSK PLC Sponsored ADR (GSK) This Year?

Here's Why Akero Therapeutics, Inc. (AKRO) Is a Great 'Buy the Bottom' Stock Now

Zacks

6 months ago

Here's Why Akero Therapeutics, Inc. (AKRO) Is a Great 'Buy the Bottom' Stock Now

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?

Zacks

6 months ago

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?

Why BankUnited, Inc. (BKU) is a Great Dividend Stock Right Now

Zacks

6 months ago

Why BankUnited, Inc. (BKU) is a Great Dividend Stock Right Now

High Bar Brands makes splash at HDAW

GlobeNewswire

6 months ago

High Bar Brands makes splash at HDAW

How to Find Strong Business Services Stocks Slated for Positive Earnings Surprises

Zacks

6 months ago

How to Find Strong Business Services Stocks Slated for Positive Earnings Surprises

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY

GlobeNewswire

6 months ago

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY

Virtu Financial, Inc. (NASDAQ:VIRT) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Virtu Financial, Inc. (NASDAQ:VIRT) Q4 2023 Earnings Call Transcript

Why DigitalOcean Holdings, Inc. (DOCN) Dipped More Than Broader Market Today

Zacks

6 months ago

Why DigitalOcean Holdings, Inc. (DOCN) Dipped More Than Broader Market Today

Thomson Reuters StreetEvents

6 months ago

Q4 2023 WesBanco Inc Earnings Call

Hot Picks: 7 Stocks Wall Street Expects to Double in 2024

InvestorPlace

6 months ago

Hot Picks: 7 Stocks Wall Street Expects to Double in 2024

Wesbanco Inc (WSBC) Reports Mixed Results Amidst Economic Headwinds

GuruFocus.com

6 months ago

Wesbanco Inc (WSBC) Reports Mixed Results Amidst Economic Headwinds

NuStar Energy L.P. (NS) Stock Jumps 18.3%: Will It Continue to Soar?

Zacks

6 months ago

NuStar Energy L.P. (NS) Stock Jumps 18.3%: Will It Continue to Soar?

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Enterprise Financial Services Corp Earnings Call

Terreno Realty Corporation Announces Redevelopment in Gardena, CA

Business Wire

6 months ago

Terreno Realty Corporation Announces Redevelopment in Gardena, CA

Enterprise Financial Services (EFSC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

6 months ago

Enterprise Financial Services (EFSC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Are Investors Undervaluing Edgewell Personal Care (EPC) Right Now?

Zacks

6 months ago

Are Investors Undervaluing Edgewell Personal Care (EPC) Right Now?

Stock Market News for Jan 18, 2024

Zacks

6 months ago

Stock Market News for Jan 18, 2024

Progress Software Corporation (NASDAQ:PRGS) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Progress Software Corporation (NASDAQ:PRGS) Q4 2023 Earnings Call Transcript

Is Now An Opportune Moment To Examine Liberty Latin America Ltd. (NASDAQ:LILA)?

Simply Wall St.

6 months ago

Is Now An Opportune Moment To Examine Liberty Latin America Ltd. (NASDAQ:LILA)?

Winners And Losers Of Q3: PagerDuty (NYSE:PD) Vs The Rest Of The Software Development Stocks

StockStory

6 months ago

Winners And Losers Of Q3: PagerDuty (NYSE:PD) Vs The Rest Of The Software Development Stocks

Bull of the Day: NeoGenomics (NEO)

Zacks

6 months ago

Bull of the Day: NeoGenomics (NEO)

Growth Stocks on the Brink: 7 Picks Poised for Explosive Returns

InvestorPlace

6 months ago

Growth Stocks on the Brink: 7 Picks Poised for Explosive Returns

Brokers Suggest Investing in Tecnoglass (TGLS): Read This Before Placing a Bet

Zacks

6 months ago

Brokers Suggest Investing in Tecnoglass (TGLS): Read This Before Placing a Bet

Mason Hawkins Adjusts Stake in Oscar Health Inc

GuruFocus.com

7 months ago

Mason Hawkins Adjusts Stake in Oscar Health Inc

Q3 Earnings Highlights: Braze (NASDAQ:BRZE) Vs The Rest Of The Sales And Marketing Software Stocks

StockStory

7 months ago

Q3 Earnings Highlights: Braze (NASDAQ:BRZE) Vs The Rest Of The Sales And Marketing Software Stocks

The 3 Best Under-$10 Stocks to Buy in January 2024

InvestorPlace

7 months ago

The 3 Best Under-$10 Stocks to Buy in January 2024

The past three years for Kennametal (NYSE:KMT) investors has not been profitable

Simply Wall St.

7 months ago

The past three years for Kennametal (NYSE:KMT) investors has not been profitable

There's Been No Shortage Of Growth Recently For GMS' (NYSE:GMS) Returns On Capital

Simply Wall St.

7 months ago

There's Been No Shortage Of Growth Recently For GMS' (NYSE:GMS) Returns On Capital

Director Laurence Charney Sells 17,500 Shares of TG Therapeutics Inc

GuruFocus.com

7 months ago

Director Laurence Charney Sells 17,500 Shares of TG Therapeutics Inc

U.S. Physical Therapy to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

7 months ago

U.S. Physical Therapy to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Gentherm Unveils WellSense™ “A Symphony of Sensations” during CES 2024

GlobeNewswire

7 months ago

Gentherm Unveils WellSense™ “A Symphony of Sensations” during CES 2024

Will Affiliated Managers (AMG) Beat Estimates Again in Its Next Earnings Report?

Zacks

7 months ago

Will Affiliated Managers (AMG) Beat Estimates Again in Its Next Earnings Report?

Do Fundamentals Have Any Role To Play In Driving U.S. Physical Therapy, Inc.'s (NYSE:USPH) Stock Up Recently?

Simply Wall St.

7 months ago

Do Fundamentals Have Any Role To Play In Driving U.S. Physical Therapy, Inc.'s (NYSE:USPH) Stock Up Recently?

Where Will ZIM Stock Be in 2024?

Motley Fool

7 months ago

Where Will ZIM Stock Be in 2024?

Cal-Maine Foods (CALM) Just Overtook the 20-Day Moving Average

Zacks

7 months ago

Cal-Maine Foods (CALM) Just Overtook the 20-Day Moving Average

Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.

GlobeNewswire

7 months ago

Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.

Collegium (COLL) Shares Rise on Financial Outlook for 2024

Zacks

7 months ago

Collegium (COLL) Shares Rise on Financial Outlook for 2024

Why Hold Strategy is Apt for Callon Petroleum (CPE) Stock Now

Zacks

7 months ago

Why Hold Strategy is Apt for Callon Petroleum (CPE) Stock Now

Akero Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Akero Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

OPENLANE Launches Visual Boost AI™ to Pinpoint Vehicle Damage

PR Newswire

7 months ago

OPENLANE Launches Visual Boost AI™ to Pinpoint Vehicle Damage

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

How ABM Industries (ABM) Stock Stands Out in a Strong Industry

Zacks

7 months ago

How ABM Industries (ABM) Stock Stands Out in a Strong Industry

CSG Systems International, Inc.'s (NASDAQ:CSGS) Intrinsic Value Is Potentially 66% Above Its Share Price

Simply Wall St.

7 months ago

CSG Systems International, Inc.'s (NASDAQ:CSGS) Intrinsic Value Is Potentially 66% Above Its Share Price

3 Magnificent High-Yield Dividend Stocks to Buy for 2024

Motley Fool

7 months ago

3 Magnificent High-Yield Dividend Stocks to Buy for 2024

Akero Therapeutics Announces First Patients Dosed in Efruxifermin Phase 3 SYNCHRONY Program

GlobeNewswire

7 months ago

Akero Therapeutics Announces First Patients Dosed in Efruxifermin Phase 3 SYNCHRONY Program

Insider Sell Alert: Chief People Officer Kimberly Rutledge Sells Shares of Q2 Holdings Inc

GuruFocus.com

7 months ago

Insider Sell Alert: Chief People Officer Kimberly Rutledge Sells Shares of Q2 Holdings Inc

HighPeak Energy, Inc.'s (NASDAQ:HPK) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Simply Wall St.

7 months ago

HighPeak Energy, Inc.'s (NASDAQ:HPK) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Insider Sell Alert: Akero Therapeutics Inc's President and CEO Andrew Cheng Disposes of 26,978 ...

GuruFocus.com

7 months ago

Insider Sell Alert: Akero Therapeutics Inc's President and CEO Andrew Cheng Disposes of 26,978 ...

Gulfport Energy Announces Pricing of Block Trade of 653,464 Shares of Common Stock by Selling Stockholders

Business Wire

8 months ago

Gulfport Energy Announces Pricing of Block Trade of 653,464 Shares of Common Stock by Selling Stockholders

PR Newswire

8 months ago

SUNSTONE HOTEL INVESTORS DECLARES FOURTH QUARTER DIVIDEND ON COMMON STOCK

12 Most Promising Stocks to Buy According to Hedge Funds

Insider Monkey

8 months ago

12 Most Promising Stocks to Buy According to Hedge Funds

Custom Truck One Source to Participate in the BofA Securities 2023 Leveraged Finance Conference

Business Wire

8 months ago

Custom Truck One Source to Participate in the BofA Securities 2023 Leveraged Finance Conference

GuruFocus.com

8 months ago

Akero Therapeutics Inc (AKRO) Reports Q3 2023 Financial Results

Akero Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

Akero Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Akero Therapeutics to Present Late-Breaking Oral and Poster Presentations on EFX at AASLD’s The Liver Meeting® 2023

GlobeNewswire

9 months ago

Akero Therapeutics to Present Late-Breaking Oral and Poster Presentations on EFX at AASLD’s The Liver Meeting® 2023

Indivior Announces Q3 2023 Financial Results

PR Newswire

9 months ago

Indivior Announces Q3 2023 Financial Results

Sunstone Hotel Investors, Inc. (NYSE:SHO) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Sunstone Hotel Investors, Inc. (NYSE:SHO) Q3 2023 Earnings Call Transcript

HighPeak Energy, Inc. (NASDAQ:HPK) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

HighPeak Energy, Inc. (NASDAQ:HPK) Q3 2023 Earnings Call Transcript

Top Dividend Stocks: A Sizzling 8.8% Yield Highlights This Commercial REIT

Investor's Business Daily

9 months ago

Top Dividend Stocks: A Sizzling 8.8% Yield Highlights This Commercial REIT

Inter&Co Inc. Reports Record Third-Quarter 2023 Net Income of R$104 Million

GlobeNewswire

9 months ago

Inter&Co Inc. Reports Record Third-Quarter 2023 Net Income of R$104 Million

These 9%-Plus Dividend Stocks Look Attractive Right Now, Says Top Analyst

TipRanks

9 months ago

These 9%-Plus Dividend Stocks Look Attractive Right Now, Says Top Analyst

Share on Social Networks: